Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-07T09:49:51.461Z Has data issue: false hasContentIssue false

Characterization of monomeric DNA-binding protein Histone H1 in Leishmania braziliensis

Published online by Cambridge University Press:  18 July 2011

EMMA CARMELO*
Affiliation:
Instituto de Enfermedades Tropicales y Salud Pública de Canarias. Universidad de La Laguna. Av. Astrofisico Fco. Sanchez, s/n. 38202 La Laguna, Tenerife, Spain
GLORIA GONZÁLEZ
Affiliation:
Instituto de Biotecnología, Universidad de Granada. Campus Fuentenueva 18071, Granada, Spain
TERESA CRUZ
Affiliation:
Instituto de Biotecnología, Universidad de Granada. Campus Fuentenueva 18071, Granada, Spain
ANTONIO OSUNA
Affiliation:
Instituto de Biotecnología, Universidad de Granada. Campus Fuentenueva 18071, Granada, Spain
MARIANO HERNÁNDEZ
Affiliation:
Instituto de Enfermedades Tropicales y Salud Pública de Canarias. Universidad de La Laguna. Av. Astrofisico Fco. Sanchez, s/n. 38202 La Laguna, Tenerife, Spain
BASILIO VALLADARES
Affiliation:
Instituto de Enfermedades Tropicales y Salud Pública de Canarias. Universidad de La Laguna. Av. Astrofisico Fco. Sanchez, s/n. 38202 La Laguna, Tenerife, Spain
*
*Corresponding author: Instituto de Enfermedades Tropicales y Salud Pública de Canarias. Universidad de La Laguna. Av. Astrofisico Fco. Sanchez, s/n. 38202 La Laguna, Tenerife, Spain. Tel: 0034 922316502 ext. 6109. Fax: 0034 922318514. E-mail: ecarmelo@ull.es
Rights & Permissions [Opens in a new window]

Summary

Histone H1 in Leishmania presents relevant differences compared to higher eukaryote counterparts, such as the lack of a DNA-binding central globular domain. Despite that, it is apparently fully functional since its differential expression levels have been related to changes in chromatin condensation and infectivity, among other features. The localization and the aggregation state of L. braziliensis H1 has been determined by immunolocalization, mass spectrometry, cross-linking and electrophoretic mobility shift assays. Analysis of H1 sequences from the Leishmania Genome Database revealed that our protein is included in a very divergent group of histones H1 that is present only in L. braziliensis. An antibody raised against recombinant L. braziliensis H1 recognized specifically that protein by immunoblot in L. braziliensis extracts, but not in other Leishmania species, a consequence of the sequence divergences observed among Leishmania species. Mass spectrometry analysis and in vitro DNA-binding experiments have also proven that L. braziliensis H1 is monomeric in solution, but oligomerizes upon binding to DNA. Finally, despite the lack of a globular domain, L. braziliensis H1 is able to form complexes with DNA in vitro, with higher affinity for supercoiled compared to linear DNA.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2011
Figure 0

Fig. 1. Phylogenetic analysis of Leishmania Histone H1 genes. Neighbor-joining tree of Histone H1 and putative Histone H1 genes from L. (Leishmania) major (LmjF), L. (Leishmania) infantum (LinJ), L. (Leishmania) mexicana (LmxM) and L. (Viannia) braziliensis (LbrM). The sequences were retrieved from Leishmania Genome Database (www.genedb.org) and aligned using ClustalW as implemented in MEGA 4 software. Bootstrap support of the branches is given in percentages at the internodes. The tree is drawn to the scale at the bottom, expressed as distance per nucleotide, and rooted with a Trypanosoma brucei H1 (Tb11.42.0005) sequence as outgroup.

Figure 1

Fig. 2. Identification and immunolocalization of Leishmania braziliensis Histone H1. (A) Coomassie blue-stained (right) SDS-PAGE (15% acrylamide) and Western-blot (left) using anti-rLbH1 (α-H1). M, molecular weight marker; rLbH1: 0·5 μg recombinant L. braziliensis Histone H1; pH1: 1 μg of perchloric acid H1 extraction. (B) Confocal immunofluorescence microscopy of L. braziliensis promastigotes stained using anti-rLbH1 (green), DAPI (blue) and Evan's blue (red) (a–b). White arrows indicate the ring-like H1 deposits. (C) Coomassie blue-stained SDS-PAGE (12% acrylamide) and Western blot using anti-rLbH1 (α-H1) and β-tubulin antibody (anti-β-tub) (Sigma-Aldrich) against Leishmania species: L.am, L. amazonensis; L.br, L. braziliensis; L.in, L. infantum; L.maj, L. major; L.trop, L. tropica.

Figure 2

Fig. 3. Analysis of the aggregation state of rLbH1 in solution. (A) Coomassie blue-stained SDS-PAGE of the DMP-cross-linking reactions of rLbH1 and BSA. M, molecular weight marker; -, reaction without DMP; 4°, 25°, 37°, DMP cross-linking reactions incubated at those temperatures; +, reaction with DMP. (B) MALDI-TOF spectrum of rLbH1 DMP-cross-linking reaction. (C) Coomassie blue-stained SDS-PAGE of rLbH1glutaraldehyde-crosslinking reactions. (D) MALDI-TOF spectrum of glutaraldehyde-cross-linking reaction.

Figure 3

Fig. 4. Analysis of the aggregation state of rLbH1 in the presence of DNA. Coomassie blue-stained SDS-PAGE of rLbH1 DMP-cross-linking reactions in the presence of H1-DB oligonucleotide. M, molecular weight marker.

Figure 4

Fig. 5. Leishmania braziliensis H1 DNA-binding in vitro. (A) Coomassie blue-stained SDS-PAGE of the UV-cross-linking reactions of rLbH1 in the presence of H1-DB oligonucleotide. M, molecular weight marker. (B) Agarose gel electrophoresis of DNA-binding reactions using 0·5 μg of supercoiled (SC) or linearised (L) pGT-RNApol II plasmid in the presence of increasing molar ratios of rLbH1. N, relaxed circular plasmid; M, λ/Hind III molecular weight marker; lanes 1 and 9: no rLbH1 added; lanes 2 and 10: 25/1 molar ratio; lanes 3 and 11: 50/1 molar ratio; lanes 4 and 12: 100/1 molar ratio; lanes 5 and 13: 200/1 molar ratio; lanes 6 and 14: 200/1 molar ratio; lanes 7 and 15: 300/1 molar ratio; lanes 9 and 16: 500/1 molar ratio. (C) Agarose gel electrophoresis of DNA-binding reactions using 0·7 μg of a PCR-amplified 219 bp fragment of L. braziliensis RNA-Polymerase II, incubated with bovine serum albumin (BSA); M: 100 bp Molecular Weight Marker XIV (Roche Diagnostics); -, reaction without BSA; +, reaction with 1000/1 molar ratio of BSA/DNA.